Clinical trial
Survivorship Care in Patients With Hematologic Cancer Undergoing HSCT: A Feasibility Study on Quality of Life, Unmet Needs, and Caregivers Burden
NCT07579065 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Survivorship Care in Patients With Hematologic Cancer Undergoing HSCT: A Feasibility Study on Quality of Life, Unmet Needs, and Caregivers Burden
- Lead sponsor
- Azienda USL Reggio Emilia - IRCCS
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 30, 2026
- Completion date
- January 31, 2028
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer survivorship, hematologic neoplasm, hematopoietic stem cell transplantation, survivorship